• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should gatifloxacin be included in the model list of essential medicines?

作者信息

Chiang Chen-Yuan, Trébucq Arnaud, Piubello Alberto, Rieder Hans L, Van Deun Armand

机构信息

International Union Against Tuberculosis and Lung Disease, Paris, France

Division of Pulmonary Medicine, Dept of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

出版信息

Eur Respir J. 2018 Feb 7;51(2). doi: 10.1183/13993003.02329-2017. Print 2018 Feb.

DOI:10.1183/13993003.02329-2017
PMID:29437946
Abstract
摘要

相似文献

1
Should gatifloxacin be included in the model list of essential medicines?加替沙星是否应列入基本药物示范清单？
Eur Respir J. 2018 Feb 7;51(2). doi: 10.1183/13993003.02329-2017. Print 2018 Feb.
2
Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?世界卫生组织基本药物示范清单能否在注射剂的安全合理使用方面发挥更大作用？
J Clin Pharmacol. 2004 Oct;44(10):1106-13. doi: 10.1177/0091270004268410.
3
On Essentiality and the World Health Organization's Model List of Essential Medicines.论必需性和世界卫生组织基本药物标准清单
Ann Glob Health. 2017 May-Aug;83(3-4):637-640. doi: 10.1016/j.aogh.2017.05.005. Epub 2017 Jun 22.
4
The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).基本药物的选择与使用。世界卫生组织专家委员会报告，2005年（包括第14版基本药物示范目录）
World Health Organ Tech Rep Ser. 2006(933):1-119, back cover.
5
[The essentiality and rationality of the Brazilian national listing of essential medicines].[巴西国家基本药物清单的必要性与合理性]
Cien Saude Colet. 2017 Mar;22(3):975-986. doi: 10.1590/1413-81232017223.07742016.
6
The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).基本药物的选择与使用。世界卫生组织专家委员会报告，2002年（包括第12版基本药物示范目录）
World Health Organ Tech Rep Ser. 2003;914:i-vi, 1-126.
7
The selection and use of essential medicines.基本药物的选择与使用。
World Health Organ Tech Rep Ser. 2008(950):backcover, vii-174.
8
The selection and use of essential medicines.基本药物的遴选与使用。
World Health Organ Tech Rep Ser. 2007(946):1-162, back cover.
9
Essential medicines for children.儿童基本药物
Arch Dis Child. 2015 Feb;100 Suppl 1:S38-42. doi: 10.1136/archdischild-2013-305705.
10
The Selection and Use of Essential Medicines.基本药物的选择与使用
World Health Organ Tech Rep Ser. 2015(994):vii-xv, 1-546.

引用本文的文献

1
Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against .氯法齐明和贝达喹啉的耐药分子机制及治疗效果
Front Med (Lausanne). 2024 Jan 10;10:1304857. doi: 10.3389/fmed.2023.1304857. eCollection 2023.
2
Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study.尼泊尔现行方案标准化方案治疗耐多药结核病患者的治疗结果：回顾性单中心研究。
BMJ Open Respir Res. 2020 Aug;7(1). doi: 10.1136/bmjresp-2020-000606.
3
High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam.
越南采用基于左氧氟沙星的短程治疗方案治疗耐多药结核病患者取得高治疗成功率且零复发
Trop Med Infect Dis. 2020 Mar 10;5(1):43. doi: 10.3390/tropicalmed5010043.
4
Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence.耐多药结核病的短程治疗方案：十年证据
J Clin Med. 2019 Dec 25;9(1):55. doi: 10.3390/jcm9010055.